Form EFFECT Avalyn Pharma Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AEP Increases Quarterly Dividend to 97 Cents a Share
- Kohler Celebrates the Art of Curation in New Collections Campaign
- AINewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Completes 1-for-150 Reverse Stock Split to Support Nasdaq Uplisting
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share